Amneals Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMNEALS PHARMS, and what generic and branded alternatives to AMNEALS PHARMS drugs are available?
AMNEALS PHARMS has one approved drug.
Drugs and US Patents for Amneals Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneals Pharms | FAMOTIDINE | famotidine | FOR SUSPENSION;ORAL | 216427-001 | Aug 4, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.